Furaquinocin B
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antibiotics |
| Catalog number | BBF-01461 |
| CAS | 125224-54-6 |
| Molecular Weight | 402.44 |
| Molecular Formula | C22H26O7 |
Online Inquiry
Description
Furaquinocin B is originally isolated from Streptomyces sp. KO-3988. It can kill HeLa S3 and B16 melanoma cells, but has no antibacterial activity.
Specification
| Synonyms | Naphtho(1,2-B)furan-6,9-dione, 3-(1,5-dihydroxy-4-methyl-3-pentenyl)-2,3-dihydro-4-hydroxy-7-methoxy-2,3,8-trimethyl-; (2R)-2α,3,8-Trimethyl-3α-[(1R,3E)-1,5-dihydroxy-4-methyl-3-pentenyl]-4-hydroxy-7-methoxy-2,3,6,9-tetrahydronaphtho[1,2-b]furan-6,9-dione |
| IUPAC Name | (2R,3S)-3-[(E,1R)-1,5-dihydroxy-4-methylpent-3-enyl]-4-hydroxy-7-methoxy-2,3,8-trimethyl-2H-benzo[g][1]benzofuran-6,9-dione |
| Canonical SMILES | CC1C(C2=C(C=C3C(=C2O1)C(=O)C(=C(C3=O)OC)C)O)(C)C(CC=C(C)CO)O |
| InChI | InChI=1S/C22H26O7/c1-10(9-23)6-7-15(25)22(4)12(3)29-21-16-13(8-14(24)17(21)22)19(27)20(28-5)11(2)18(16)26/h6,8,12,15,23-25H,7,9H2,1-5H3/b10-6+/t12-,15-,22-/m1/s1 |
| InChI Key | FBOIBFWCHWNBOE-PLNKERHHSA-N |
Properties
| Appearance | Yellow Acicular Crystalline |
| Antibiotic Activity Spectrum | neoplastics (Tumor) |
| Melting Point | 101-104°C |
Reference Reading
1. Total syntheses of furaquinocin A, B, and E
Barry M Trost, Oliver R Thiel, Hon-Chung Tsui J Am Chem Soc. 2003 Oct 29;125(43):13155-64. doi: 10.1021/ja0364118.
A modular approach to the total synthesis of furaquinocins culminated in the total syntheses of furaquinocin A, B, and E. A Pd-catalyzed dynamic kinetic asymmetric transformation (DYKAT) on carbonates derived from Baylis-Hillman adducts, followed by a reductive Heck cyclization allows the enantio- and diastereoselective construction of dihydrobenzofuran 32. Introduction of a double unsatured side chain via Horner-Wadsworth-Emmons reaction and assembly of the naphthoquinone with squaric acid based methodology leads to furaquinocin E. The use of differentially substituted squaric acid derivatives allows the synthesis of three analogues of furaquinocin E. The additional stereocenters in furaquinocin A and B can be introduced with a diastereoselective Sakurai allylation. The stereoselective elongation of the side chain is possible using cross metathesis or ring closing metathesis. The obtained late-stage intermediates were successfully transformed to furaquinocin A and B.
2. Novel antibiotics, furaquinocins A and B. Taxonomy, fermentation, isolation and physico-chemical and biological characteristics
K Komiyama, S Funayama, Y Anraku, M Ishibashi, Y Takahashi, S Omura J Antibiot (Tokyo). 1990 Mar;43(3):247-52. doi: 10.7164/antibiotics.43.247.
Two novel antibiotics, furaquinocins A and B were isolated from the culture broth of Streptomyces sp. KO-3988. These antibiotics possess cytocidal activities against HeLa S3 cells in vitro at concentrations of 3.1 micrograms/ml for A and 1.6 micrograms/ml for B. Neither substance possessed antimicrobial activities against Gram-positive and Gram-negative bacteria, fungi or yeast at a concentration of 1,000 micrograms/ml.
3. Furaquinocins K and L: Novel Naphthoquinone-Based Meroterpenoids from Streptomyces sp. Je 1-369
Stepan Tistechok, Marc Stierhof, Maksym Myronovskyi, Josef Zapp, Oleksandr Gromyko, Andriy Luzhetskyy Antibiotics (Basel). 2022 Nov 10;11(11):1587. doi: 10.3390/antibiotics11111587.
Actinomycetes are the most prominent group of microorganisms that produce biologically active compounds. Among them, special attention is focused on bacteria in the genus Streptomyces. Streptomycetes are an important source of biologically active natural compounds that could be considered therapeutic agents. In this study, we described the identification, purification, and structure elucidation of two new naphthoquinone-based meroterpenoids, furaquinocins K and L, from Streptomyces sp. Je 1-369 strain, which was isolated from the rhizosphere soil of Juniperus excelsa (Bieb.). The main difference between furaquinocins K and L and the described furaquinocins was a modification in the polyketide naphthoquinone skeleton. In addition, the structure of furaquinocin L contained an acetylhydrazone fragment, which is quite rare for natural compounds. We also identified a furaquinocin biosynthetic gene cluster in the Je 1-369 strain, which showed similarity (60%) with the furaquinocin B biosynthetic gene cluster from Streptomyces sp. KO-3988. Furaquinocin L showed activity against Gram-positive bacteria without cytotoxic effects.
Recommended Products
| BBF-01693 | Doxorubicin EP Impurity A (Daunorubicin) | Inquiry |
| BBF-03753 | Baicalin | Inquiry |
| BBF-01829 | Deoxynojirimycin | Inquiry |
| BBF-02614 | Nystatin | Inquiry |
| BBF-03754 | Castanospermine | Inquiry |
| BBF-05862 | Epirubicin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
